Globus Medical Cash Flow from Investing Activities 2010-2023 | GMED
Globus Medical annual/quarterly cash flow from investing activities history and growth rate from 2010 to 2023. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
- Globus Medical cash flow from investing activities for the quarter ending December 31, 2023 was $0.303B, a 374.52% decline year-over-year.
- Globus Medical cash flow from investing activities for the twelve months ending December 31, 2023 was $0.360B, a 323.44% decline year-over-year.
- Globus Medical annual cash flow from investing activities for 2023 was $0.303B, a 374.52% decline from 2022.
- Globus Medical annual cash flow from investing activities for 2022 was $-0.11B, a 70.64% decline from 2021.
- Globus Medical annual cash flow from investing activities for 2021 was $-0.376B, a 220.43% increase from 2020.
| Globus Medical Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2023 | $303 |
| 2022 | $-110 |
| 2021 | $-376 |
| 2020 | $-117 |
| 2019 | $-140 |
| 2018 | $-193 |
| 2017 | $-111 |
| 2016 | $-163 |
| 2015 | $-153 |
| 2014 | $-100 |
| 2013 | $-227 |
| 2012 | $-31 |
| 2011 | $-30 |
| 2010 | $-12 |
| 2009 | $-28 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.718B | $1.568B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $227.236B | 27.53 |
| Intuitive Surgical (ISRG) | United States | $141.461B | 85.22 |
| Edwards Lifesciences (EW) | United States | $53.716B | 34.96 |
| DexCom (DXCM) | United States | $52.240B | 79.13 |
| IDEXX Laboratories (IDXX) | United States | $44.882B | 52.61 |
| Alcon (ALC) | Switzerland | $43.802B | 31.39 |
| IQVIA Holdings (IQV) | United States | $42.121B | 24.44 |
| STERIS (STE) | Ireland | $22.993B | 26.87 |
| Waters (WAT) | United States | $21.115B | 31.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.146B | 0.00 |
| Hologic (HOLX) | United States | $17.508B | 19.59 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.893B | 15.05 |
| ShockWave Medical (SWAV) | United States | $12.394B | 77.13 |
| Sysmex ADR (SSMXY) | Japan | $11.077B | 34.74 |
| Teleflex (TFX) | United States | $10.251B | 15.96 |
| Penumbra (PEN) | United States | $7.890B | 89.66 |
| Masimo (MASI) | United States | $6.588B | 37.95 |
| Glaukos (GKOS) | United States | $5.530B | 0.00 |
| TransMedics (TMDX) | United States | $4.545B | 431.19 |
| Integer Holdings (ITGR) | United States | $4.051B | 24.48 |
| PROCEPT BioRobotics (PRCT) | United States | $3.502B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.355B | 19.92 |
| Tandem Diabetes Care (TNDM) | United States | $3.055B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.926B | 20.07 |
| Inari Medical (NARI) | United States | $2.660B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.485B | 21.02 |
| RxSight (RXST) | United States | $2.243B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.170B | 9.46 |
| Veracyte (VCYT) | United States | $1.749B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.546B | 0.00 |
| Artivion (AORT) | United States | $0.978B | 93.84 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.936B | 18.20 |
| OPKO Health (OPK) | United States | $0.920B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.875B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.763B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.659B | 22.39 |
| Paragon 28 (FNA) | United States | $0.635B | 0.00 |
| SiBone (SIBN) | United States | $0.615B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.563B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.550B | 0.00 |
| IRadimed (IRMD) | United States | $0.532B | 29.81 |
| Pulse Biosciences (PLSE) | United States | $0.431B | 0.00 |
| Nevro (NVRO) | United States | $0.419B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.326B | 11.16 |
| Treace Medical Concepts (TMCI) | United States | $0.310B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.266B | 0.00 |
| AxoGen (AXGN) | United States | $0.264B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.249B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.242B | 0.00 |
| 908 Devices (MASS) | United States | $0.236B | 0.00 |
| NeuroPace (NPCE) | United States | $0.235B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.210B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.197B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.197B | 0.00 |
| CVRx (CVRX) | United States | $0.179B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.170B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.163B | 8.25 |
| Accuray (ARAY) | United States | $0.162B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.108B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.097B | 20.45 |
| Yubo Biotech (YBGJ) | China | $0.095B | 0.00 |
| Neuronetics (STIM) | United States | $0.078B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.066B | 0.00 |
| Hyperfine (HYPR) | United States | $0.064B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.062B | 0.00 |
| Envoy Medical (COCH) | United States | $0.061B | 0.00 |
| InspireMD (NSPR) | Israel | $0.057B | 0.00 |
| DarioHealth (DRIO) | United States | $0.057B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.049B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.047B | 0.00 |
| LENSAR (LNSR) | United States | $0.047B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.033B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.031B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.029B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.015B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.010B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |